Nobivac™ Lyme: A powerful new weapon against Lyme disease

Now, there’s a new-generation Lyme vaccine that protects against this debilitating disease on two important fronts. Nobivac™ Lyme was specifically designed to stimulate high levels of borreliacidal antibodies to key outer surface proteins (Osps) involved in the transmission of Lyme disease—OspA and OspC. With this unique, powerful dual protection, Nobivac™ Lyme is highly effective in eliminating B. burgdorferi from ticks and preventing infection in dogs.

PreveNile™ West Nile Virus vaccine

For the vaccination of healthy horses to prevent viremia and as an aid in the prevention of disease and encephalitis caused by West Nile virus infection.

For more information visit the PreveNile™ website

A trusted source...

Intervet/Schering-Plough Animal Health is a global leader in the discovery, development, manufacture and sale of veterinary medicines. The result of the combination of two major companies in the animal health sector, our company offers customers one of the industry's broadest, most innovative portfolios, spanning products to support performance and to prevent, treat and control disease in all major farm and companion animal species.

The combination of Intervet and Schering-Plough Animal Health (SPAH) has married two complementary product ranges, strengthening our portfolio and broadening our global reach. We now have offices in more than 50 countries and sell our products in over 140 markets. We operate a network of manufacturing sites and research and development facilities around the world.

What's New?

Stop/Sale Recall for Jencine 4

Stop/Sale Recall for Jencine 4 (Bovine Rhinotracheitis-Respiratory Syncytial Virus - Viral Diarrhea-Parainfluenza 3 Vaccine, Modified Live Virus); serials 226178 consecutively, through 226192, and Jencine 4 that are in combination with Lepto-5.

For more information and FAQ's click here...

Intervet Inc.